QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NYSE:HIMS

Hims & Hers Health (HIMS) Stock Forecast, Price & News

$6.22
-0.23 (-3.57%)
(As of 10/3/2023 ET)
Compare
Today's Range
$6.17
$6.45
50-Day Range
$6.02
$8.97
52-Week Range
$4.01
$12.34
Volume
2.95 million shs
Average Volume
3.03 million shs
Market Capitalization
$1.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.75

Hims & Hers Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
88.9% Upside
$11.75 Price Target
Short Interest
Bearish
12.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.86mentions of Hims & Hers Health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.26 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.15) to ($0.07) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

566th out of 976 stocks

Offices & Clinics Of Medical Doctors Industry

2nd out of 6 stocks


HIMS stock logo

About Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

HIMS Price History

HIMS Stock News Headlines

2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. (NASDAQ: ULTA) and Estee Lauder Co. (NYSE: EL) shares
Is Hims & Hers Health Stock a Buy Now?
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Hims & Hers Health: Can't Get Much Better
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $42,666.32 in Stock
Hims and Hers Stock Analysis: Buy or Sell?
Hims & Hers: Myopic Shorts, Absurdly Cheap
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
The Market Is Wrong On Hims & Hers Health
Hims & Hers Q2 Earnings: Portfolio Cure
Hims (ED) Review 2023
See More Headlines
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Company Calendar

Last Earnings
8/07/2023
Today
10/03/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
651
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.75
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+88.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$-65,680,000.00
Pretax Margin
-6.58%

Debt

Sales & Book Value

Annual Sales
$526.92 million
Book Value
$1.50 per share

Miscellaneous

Free Float
144,276,000
Market Cap
$1.31 billion
Optionable
Optionable
Beta
0.54
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Andrew DudumMr. Andrew Dudum (Age 34)
    Co-Founder, Chairman & CEO
    Comp: $1.7M
  • Mr. Yemi Okupe (Age 37)
    Chief Financial Officer
    Comp: $804.05k
  • Ms. Melissa BairdMs. Melissa Baird (Age 45)
    Chief Operating Officer
    Comp: $917.67k
  • Ms. Irene A. Becklund (Age 38)
    Sr. VP, Controller & Principal Accounting Officer
    Comp: $361.12k
  • Ms. Soleil Teubner Boughton (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $782.66k
  • Mr. Mike Chi (Age 43)
    Chief Marketing Officer
    Comp: $514.77k
  • Dr. Patrick Carroll M.D. (Age 65)
    Chief Medical Officer, Member of Medical Advisory Board & Director
    Comp: $27.03k
  • Mr. Brian O'Shaughnessy
    Chief Communications Officer
  • Ms. Amee Parekh
    Sr. VP of HR
  • Mr. Jonathan Spitzer C.F.A.
    Sr. VP of Investor Relations













HIMS Stock - Frequently Asked Questions

Should I buy or sell Hims & Hers Health stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HIMS shares.
View HIMS analyst ratings
or view top-rated stocks.

What is Hims & Hers Health's stock price forecast for 2023?

10 brokerages have issued 12 month target prices for Hims & Hers Health's stock. Their HIMS share price forecasts range from $5.00 to $18.00. On average, they expect the company's stock price to reach $11.75 in the next year. This suggests a possible upside of 88.9% from the stock's current price.
View analysts price targets for HIMS
or view top-rated stocks among Wall Street analysts.

How have HIMS shares performed in 2023?

Hims & Hers Health's stock was trading at $6.41 on January 1st, 2023. Since then, HIMS shares have decreased by 3.0% and is now trading at $6.22.
View the best growth stocks for 2023 here
.

Are investors shorting Hims & Hers Health?

Hims & Hers Health saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 16,650,000 shares, a decrease of 5.8% from the August 15th total of 17,680,000 shares. Based on an average daily trading volume, of 2,990,000 shares, the short-interest ratio is currently 5.6 days. Approximately 12.4% of the company's stock are sold short.
View Hims & Hers Health's Short Interest
.

When is Hims & Hers Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our HIMS earnings forecast
.

How were Hims & Hers Health's earnings last quarter?

Hims & Hers Health, Inc. (NYSE:HIMS) released its quarterly earnings results on Monday, August, 7th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.03. The firm earned $207.91 million during the quarter, compared to analyst estimates of $204.95 million. Hims & Hers Health had a negative trailing twelve-month return on equity of 14.97% and a negative net margin of 6.61%. The firm's quarterly revenue was up 83.1% on a year-over-year basis. During the same period in the prior year, the business earned ($0.10) EPS.

What guidance has Hims & Hers Health issued on next quarter's earnings?

Hims & Hers Health issued an update on its third quarter 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $217.00 million-$222.00 million, compared to the consensus revenue estimate of $213.78 million.

What is Hims & Hers Health's stock symbol?

Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS."

How do I buy shares of Hims & Hers Health?

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hims & Hers Health's stock price today?

One share of HIMS stock can currently be purchased for approximately $6.22.

How much money does Hims & Hers Health make?

Hims & Hers Health (NYSE:HIMS) has a market capitalization of $1.31 billion and generates $526.92 million in revenue each year. The company earns $-65,680,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.

How many employees does Hims & Hers Health have?

The company employs 651 workers across the globe.

How can I contact Hims & Hers Health?

Hims & Hers Health's mailing address is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. The official website for the company is www.forhims.com. The company can be reached via phone at 415-851-0195 or via email at hims-ir@westwicke.com.

This page (NYSE:HIMS) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -